rSj16, a recombinant protein of Schistosoma japonicum-derived molecule, reduces severity of the complete Freund's adjuvant-induced adjuvant arthritis in rats' model

Parasite Immunology

Volumn 32, Issue 11-12, 2010, Pages 739-748

  Sun, X ^a,b   Liu, Y H ^a,b   Lv, Z Y ^a,b   Yang, L L ^a,b   Hu, S M ^c   Zheng, H Q ^a,b   Hu, W ^d   Cao, J P ^d   Fung, M Q ^c   Wu, Z D ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Adjuvant arthritis; Anti inflammatory; Dendritic cell; Rat; RSj16

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; DEXAMETHASONE; FREUND ADJUVANT; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 4; NITRIC OXIDE; PROTEIN RSJ16; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG MECHANISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SCHISTOSOMA JAPONICUM; T LYMPHOCYTE;

RATTUS; SCHISTOSOMA JAPONICUM;

EID: 78650426772     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2010.01240.x     Document Type: Article

References (38)

1. Scott DL, Shipley M, Dawson A, Edwards S, Symmons DP & Woolf AD. The clinical management of rheumatoid arthritis and osteoarthritis: strategies for improving clinical effectiveness. Br J Rheumatol 1998; 37: 546-554.
2. Pincus T, Marcum SB & Callahan LF. Long-term drug therapy for rheumatoid arthritis in seven rheumatology private practices. Second line drugs and prednisone. J Rheumatol 1992; 19: 1885-1894.
3. Sewell DL, Reinke EK, Hogan LH, Sandor M & Fabry Z. Immunoregulation of CNS autoimmunity by helminth and mycobacterial infections. Immunol Lett 2002; 82: 101-110.
4. Beighton PL, Solomon L & Valkenburg HA. Rheumatoid arthritis in a rural South African Negro population. Ann Rheum Dis 1975; 34: 136-141.
5. Osada Y, Shimizu S, Kumagai T, Yamada S & Kanazawa T. Schistosoma mansoni infection reduces severity of collagen-induced arthritis via down-regulation of pro-inflammatory mediators. Int J Parasitol 2009; 39: 457-464.
6. Hu S, Wu ZD, Yang L & Fung MC. Molecular cloning and expression of a functional anti-inflammatory protein, Sj16, of Schistosoma japonicum. Int J Parasitol 2008; 39: 191-200.
7. Sun X, Zhou HJ, Lv ZY, et al. Studies on Immunomodulation Effect of Recombinant Sj16 from Schistosoma japonicum on Inflammation Response of Host. Chin J Parasitol Parasit Dis 2008; 26: 113-118.
8. Colpaert FC. Evidence that adjuvant arthritis in the rat is associated with chronic pain. Pain 1987; 28: 201-222.
9. Butler SH, Godefroy F, Besson JM & Weil-Fugazza J. A limited arthritic model for chronic pain studies in the rat. Pain 1992; 48: 73-81.
10. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
11. Newbould BB. Chemotherapy of arthritis induced in rats by mycobacterium adjuvant. Br J Pharmacol Chenother 1963; 21: 127-136.
12. Omura K, Imai S, Maeda T & Hukuda S. Prolonged and increasing expression of Fos related antigens in the hippocampus of adjuvant arthritic rats. J Rheumatol 1998; 25: 936-944.
13. Zhang L, Li J, Yu SC, et al. Therapeutic effects and mechanisms of total flavonoids of Turpinia Arguta Seen on adjuvant arthritis in rats. J Ethnopharmacol 2008; 116: 167-172.
14. Talmor M, Mirza A, Turley S, Mellman I, Hoffman LA & Steinman RM. Generation of large numbers of immature and mature dendritic cells from rat bone marrow cultures. Eur J Immunol 1998; 28: 811-817.
15. Kim JY, Kang JS, Kim HM, et al. Inhibition of phenotypic and functional maturation of dendritic cells by Manassantin A. J Pharmacol Sci 2009; 109: 593-596.
16. + T cells by rat bone marrow-derived dendritic cells induces concurrent secretion of IFN-γ IL-4 and IL-10. Immunol Lett 2005; 101: 193-201.
17. Yoshio O & Tamotsu K. Parasitic helminths: new weapons against immunological disorders. J Biomed Biotechnol 2010; 2010: 743758.
18. Chu CQ, Field M, Feldmann M & Maini RN. Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 1991; 34: 1125-1132.
19. Niki Y, Yamada H, Kikuchi T, Toyama Y & Matsumoto H. Membrane-associated IL-1 contributes to chronic synovitis and cartilage destruction in human IL-1 alpha transgenic mice. J Immunol 2004; 172: 577-584.
20. Kaneko M, Tomita T, Nakase T, et al. Expression of proteinases and inflammatory cytokines in subchondral bone regions in the destructive joint in rheumatoid arthritis. Rheumatology 2001; 3: 247-255.
21. Arend WP & Dayer JM. The role of cytokines and their inhibitors in arthritis. Baillieres Clin Rheumatol 1995; 6: 151-160.
22. Moreland LW, Schiff MH, Baumgartner SW, et al. Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann Intern Med 1999; 130: 478-486.
23. Ralston SH, Ho LP, Helfrich MH, Grabowski PS, Johnston PW & Benjamin N. Nitric oxide: a cytokine-induced regulator of bone resorption. J Bone Miner Res 1995; 10: 1040-1049.
24. Frenkel SR, Clancy RM, Ricci JL, Di Cesare PE, Rediske JJ & Abramson SB. Effects of nitric oxide on chondrocyte migration, adhesion, and cytoskeletal assembly. Arthritis Rheum 1996; 39: 1905-1912.
25. Pelletier JP, Minean F & Ranger P. The synthesis of nitric oxide induced by IL-1 in human chondmcytes markedly reduced the synthesis of IL-1 receptor antagonist (IL-1ra): a possible role in osteoarthritic cartilage degradation. Trans Orthop Res Soc 1995; 20: 352-355.
26. Persson S, Mikulowska A, Narula S, O'Garra A & Holmdahl R. Interleukin-10 suppresses the development of collagen type IIinduced arthritis and ameliorates sustained arthritis in rats. Scand J Immunol 1996; 44: 607-614.
27. Katsikis PD, Chu CQ, Brennan FM, Maini RN & Feldmann M. Immumoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 1994; 179: 1517-1527.
28. Keystone E, Wherry J & Grint P. IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritis. Rheum Dis Clin North Am 1998; 24: 629-639.
29. Banchereau J & Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-252.
30. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767-811.
31. Lebre MC & Tak PP. Dendritic cell subsets: their roles in rheumatoid arthritis. Acta Reumatol Port 2008; 33: 35-45.
32. Thomas R, Davis LS & Lipsky PE. Rheumatoid synovium is enriched in mature antigen-presenting dendritic cells. J Immunol 1994; 152: 2613-2623.
33. Kawai T & Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11: 373-384.
34. Reinout VC, Tom HMO & Jos WM. Innate Immunity to Mycobacterium tuberculosis. Clin Microbiol Rev 2002; 2: 294-309.
35. Macatonia SE, Hosken NA, Litton M, Vieira P, Hsieh CS & Culpepper JA. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol 1999; 154: 5071-5079.
36. Whelan M, Harnmett MM, Houston KM, Patel V, Harnett W & Rigley KP. A filarial nematodesecreted product signals dendritic cells to acquire a phenotype that drives development of Th2 cells. J Immunol 2000; 164: 6453-6460.
37. Cervi L, MacDonald AS & Kane C. Cutting edge: dendritic cells copulsed with microbial and helminths antigens undergo modified maturation, segregate the antigens to distinct intracellular compartments, and concurrently induce microbe-specific Th1 and helminth-specific Th2 response. J Immunol 2004; 172: 2016-2020.
38. Hamilton CM, Dowling DJ, Loscher CE, Morphew RM, Brophy PM & O'Neill SM. The Fasciola hepatica tegumental antigen suppresses dendritic cell maturation and function. Infect Immun 2009; 77: 2488-2498.